Recommendations for inhaled nitric oxide treatment in the newborn

The recommendations in this document describe the current indications for inhaled nitric oxide (iNO) treatment in the newborn and clearly distinguish between those supported by scientific evidence and those for which evidence is still lacking, such as its use in preterm infants. The methodology for...

Full description

Saved in:
Bibliographic Details
Published in:Anales de pediatría (Barcelona, Spain : 2003) Spain : 2003), 2006-03, Vol.64 (3), p.260-266
Main Authors: Figueras Aloy, J, Castillo Salinas, F, Elorza Fernández, D, Sánchez-Luna, M, Pérez Rodríguez, J
Format: Article
Language:Spanish
Subjects:
Administration, Inhalation
Endothelium-Dependent Relaxing Factors - administration & dosage
Heart Defects, Congenital
Hernias, Diaphragmatic, Congenital
Humans
Infant, Newborn
Infant, Newborn, Diseases - therapy
Infant, Premature
Nitric Oxide - administration & dosage
Persistent Fetal Circulation Syndrome
Respiratory Distress Syndrome, Newborn
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The recommendations in this document describe the current indications for inhaled nitric oxide (iNO) treatment in the newborn and clearly distinguish between those supported by scientific evidence and those for which evidence is still lacking, such as its use in preterm infants. The methodology for iNO administration, its dosage and the main secondary effects are discussed, and the reasons for lack of response to this treatment are analyzed.
ISSN:1695-4033